基本信息
views: 3
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Velculescu is internationally known for his discoveries in genomics and cancer research. He and his colleagues performed the first genome-wide sequence analysis in human cancers, identifying key genes and pathways dysregulated in tumorigenesis. He developed methods for global gene expression analyses and coined the word “transcriptome" to describe the patterns that could now obtained in cancer and other cells. This research has revealed the genomic landscape of human cancers, including in breast, colorectal, brain, pancreatic, ovarian, head and neck, and lung cancers. These analyses identified a variety of genes not previously known to be involved in neoplasia, including PIK3CA as one of the most highly mutated genes in human cancer. More recently, his group has developed non-invasive liquid biopsies approaches for early detection and monitoring of cancer patients. These discoveries provide new paradigms for our understanding of human cancer, and have created opportunities for precision diagnostics and personalized medicine for oncology and other diseases.
Dr. Velculescu is Professor of Oncology and Pathology and Co-Director of Cancer Biology at the Sidney Kimmel Cancer Center at the Johns Hopkins University School of Medicine. He has a B.S. from Stanford University, and M.D., Ph.D. degrees from Johns Hopkins University School of Medicine. Dr. Velculescu has served as a member of the Board of Directors of the American Association of Cancer Research (AACR), as a member of scientific advisory boards of Ludwig Cancer Research, Cancer Research UK, Harvard Cancer Center, Tisch Cancer Center at Mount Sinai, Mark Foundation, and the White House Cancer Moonshot, and is a founder of Personal Genome Diagnostics. He is the recipient of several awards for his work including the Grand Prize Winner of the Amersham/Pharmacia & Science Young Scientist Prize (1999), Judson Daland Prize of the American Philosophical Society (2008), the European Association of Cancer Research and Carcinogenesis Young Investigator Award (2008), the AACR Award for Outstanding Achievement in Cancer Research (2009), the Paul Marks Prize for Cancer Research (2011), the EY Entrepreneur of the Year Award for Maryland (2016), and with his colleagues, the AACR Team Science Award for Research in Pancreatic Cancer (2013), Brain Cancer (2014), and Liquid Biopsies (2017).
Dr. Velculescu is Professor of Oncology and Pathology and Co-Director of Cancer Biology at the Sidney Kimmel Cancer Center at the Johns Hopkins University School of Medicine. He has a B.S. from Stanford University, and M.D., Ph.D. degrees from Johns Hopkins University School of Medicine. Dr. Velculescu has served as a member of the Board of Directors of the American Association of Cancer Research (AACR), as a member of scientific advisory boards of Ludwig Cancer Research, Cancer Research UK, Harvard Cancer Center, Tisch Cancer Center at Mount Sinai, Mark Foundation, and the White House Cancer Moonshot, and is a founder of Personal Genome Diagnostics. He is the recipient of several awards for his work including the Grand Prize Winner of the Amersham/Pharmacia & Science Young Scientist Prize (1999), Judson Daland Prize of the American Philosophical Society (2008), the European Association of Cancer Research and Carcinogenesis Young Investigator Award (2008), the AACR Award for Outstanding Achievement in Cancer Research (2009), the Paul Marks Prize for Cancer Research (2011), the EY Entrepreneur of the Year Award for Maryland (2016), and with his colleagues, the AACR Team Science Award for Research in Pancreatic Cancer (2013), Brain Cancer (2014), and Liquid Biopsies (2017).
Research Interests
Papers共 463 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer Researchno. 6_Supplement (2024): 4339-4339
Lavanya Sivapalan,Bahar Alipanahi,Archana Balan,Jamie E. Medina,Noushin Niknafs, Erica Peters, Jaime Wehr,Alissa Konicki, Mimi Najjar,Bryan Chesnick,Gavin Pereira, Sarah Rongione,
Cancer Researchno. 6_Supplement (2024): 6557-6557
Cancer Researchno. 6_Supplement (2024): 981-981
Cancer Researchno. 6_Supplement (2024): 974-974
Ingrid Franken,Suzanna Schraa,Karlijn van Rooijen, Dave van der Kruijssen,Carmen Rubio-Alarcón, Steven Ketelaars, Sietske van Nassau, Teunise Snetselaar, Bregje Adriaans,Jillian Phallen,Sam Angiuoli,Amy Greer,
Cancer Researchno. 6_Supplement (2024): 5022-5022
Denise E. van Steijn,Remond J. Fijneman,Geraldine R. Vink,Jeanine M. Roodhart,Miriam Koopman,Max J. Lahaye, Manon N.G. Braat,Veerle M. Coupé, Daan A. van den Broek,Gerrit A. Meijer, Haoyue Wang,Marjolein J. Greuter,
Cancer Researchno. 6_Supplement (2024): 3673-3673
Blair V. Landon, Guneet Kaleka,Archana Balan, Julia L. Boland,Christopher Cherry,Gavin Pereira,Cynthia Zahnow,Boris Winterhoff,Stephen Baylin,Victor E. Velculescu,Gottfried E. Konecny, John A. Glaspy,
Cancer Researchno. 6_Supplement (2024): 7551-7551
Sarah Short,Akshaya V. Annapragada,Jamie E. Medina,Zachariah H. Foda,Dimitrios Mathios,Carolyn Hruban, Elaine J. Chiao,Kavya Boyapati, Adrianna Bartolomucci, Keerti Boyapati,Vilmos Adleff,Robert B. Scharpf,
Cancer Researchno. 6_Supplement (2024): 982-982
Cancer Researchno. 6_Supplement (2024): 6551-6551
Load More
Author Statistics
#Papers: 457
#Citation: 109652
H-Index: 120
G-Index: 264
Sociability: 8
Diversity: 3
Activity: 185
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn